Kilitch Drugs India Q4 Results

  • BSE: 524500
  • NSE: KILITCH
  • ISIN: INE729D01010
  • Sector: Biotechnology & Drugs
BSE
306.6-2.45 (-0.79%)
Volume895.00
Updated: Mon 25 Nov, 2024 | 15:28:12
NSE
307.45-2.60 (-0.84%)
Volume7.09 K
Updated: Mon 25 Nov, 2024 | 15:31:32
Today: 306.60
316.25
52-Wk: 298.45
469.85

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Kilitch Drugs India Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 44.8229.97-%45.48-%
    Selling/ General/ Admin Expenses Total 2.372.98-%2.89-%
    Depreciation/ Amortization 0.930.93-%0.91-%
    Other Operating Expenses Total 5.007.18-%5.40-%
    Total Operating Expense 38.6726.92-%40.18-%
    Operating Income 6.153.05-%5.30-%
    Net Income Before Taxes 5.302.45-%5.11-%
    Net Income 3.592.37-%3.56-%
    Diluted Normalized EPS 2.241.52-%2.28-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts